ANALYSTS WARN OF HIGH DILUTION
Auxilium to gain Canadian footprint, better tax rate, with QLT merger
By Karen Pihl-Carey
Thursday, June 26, 2014
Visudyne developer QLT Inc. brings more than a Canadian address and its synthetic retinoid program to men's health care firm Auxilium Pharmaceuticals Inc. It brings the potential for a more favorable tax rate.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.